State-of-the-Art Cancer Biology, Biodiagnostics and Therapeutics in Japan
- PMID: 38001906
- PMCID: PMC10669596
- DOI: 10.3390/biomedicines11112905
State-of-the-Art Cancer Biology, Biodiagnostics and Therapeutics in Japan
Abstract
Early cancer detection is key to improving patient survival and quality of life and reducing cancer treatments' financial burden [...].
Conflict of interest statement
J.Y., E.d.L. and T.H. are employees of Hirotsu Bio Science Inc.
Similar articles
-
Influence of financial burden on withdrawal or change of cancer treatment in Japan: results of a bereavement survey.Support Care Cancer. 2022 Jun;30(6):5115-5123. doi: 10.1007/s00520-022-06933-7. Epub 2022 Mar 1. Support Care Cancer. 2022. PMID: 35230531
-
Financial Literacy, Financial Education, and Cancer Screening Behavior: Evidence from Japan.Int J Environ Res Public Health. 2022 Apr 7;19(8):4457. doi: 10.3390/ijerph19084457. Int J Environ Res Public Health. 2022. PMID: 35457329 Free PMC article.
-
Financial Burden and Employment Support for Patients with Cancer in Japan: A Review.Jpn Hosp. 2016 Aug;(35):53-76. Jpn Hosp. 2016. PMID: 30226962 Review.
-
Retraction statement. Paper by Manizate et al., entitled 'Liver functional reserve estimation: state of the art and relevance to local treatments' Oncology 2010;78(Suppl 1):131-134, DOI: 10.1159/000315241.Oncology. 2014;87(5):320. doi: 10.1159/000366537. Epub 2014 Sep 3. Oncology. 2014. PMID: 25196909 No abstract available.
-
Financial Toxicity: Limitations and Challenges When Caring for Older Adult Patients With Cancer.Clin J Oncol Nurs. 2018 Dec 1;22(6):43-48. doi: 10.1188/18.CJON.S2.43-48. Clin J Oncol Nurs. 2018. PMID: 30452018 Review.
References
Publication types
LinkOut - more resources
Full Text Sources